Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see. Just two drops of blood is all it takes — that is Sight Diagnostics’ promise to analyze, in a matter of seconds, any anomalies present. This point-of-care blood diagnostics system, called Olo, was launched in late 2018, and […]

To read the full article

OR